Nanos Acquires 100% Stake in US-based Nanos Biotech
[Asia Economy Reporter Ji Yeon-jin] Nanos announced on the 21st that it will acquire 100% (2 million shares) of the U.S. company Nanos Biotech, a developer of immune cell therapeutics, for approximately 11.8 billion KRW.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
The company explained, "We aim to strengthen corporate competitiveness by newly entering the pharmaceutical and bio business sector."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
